Trial intelligence / Profile preview

Para-Tyrosine Supplementation in Sepsis

NCT03278730Phase 2Suspended

Sponsor
University of Pécs
Start
Jan 2027
Primary completion
Jan 2027
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of tyrosine in sepsis, sponsored by University of Pécs. Planned start Jan 2027; status: suspended.

02

Drugs

tyrosine
03

Conditions

sepsis

Beyond the preview

Go deeper on NCT03278730.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03278730.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call